520 related articles for article (PubMed ID: 19380775)
1. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
[TBL] [Abstract][Full Text] [Related]
3. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
Shier P; Ngo K; Fung-Leung WP
J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
[TBL] [Abstract][Full Text] [Related]
4. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.
Telford WG; Nam SY; Podack ER; Miller RA
Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701
[TBL] [Abstract][Full Text] [Related]
5. Galectin-2 suppresses contact allergy by inducing apoptosis in activated CD8+ T cells.
Loser K; Sturm A; Voskort M; Kupas V; Balkow S; Auriemma M; Sternemann C; Dignass AU; Luger TA; Beissert S
J Immunol; 2009 May; 182(9):5419-29. PubMed ID: 19380789
[TBL] [Abstract][Full Text] [Related]
6. Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo.
Dubois PM; Pihlgren M; Tomkowiak M; Van Mechelen M; Marvel J
J Immunol; 1998 Nov; 161(10):5260-7. PubMed ID: 9820498
[TBL] [Abstract][Full Text] [Related]
7. A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic CD3 zeta-deficient mice.
Yamazaki T; Arase H; Ono S; Ohno H; Watanabe H; Saito T
J Immunol; 1997 Feb; 158(4):1634-40. PubMed ID: 9029099
[TBL] [Abstract][Full Text] [Related]
8. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.
Johnson KG; LeRoy FG; Borysiewicz LK; Matthews RJ
J Immunol; 1999 Apr; 162(7):3802-13. PubMed ID: 10201897
[TBL] [Abstract][Full Text] [Related]
9. Differential requirements for NF-kappaB and AP-1 trans-activation in response to minimal TCR engagement by a partial agonist in naive CD8 T cells.
Auphan N; Ghosh S; Flavell RA; Schmitt-Verhulst AM
J Immunol; 1999 Nov; 163(10):5219-27. PubMed ID: 10553042
[TBL] [Abstract][Full Text] [Related]
10. TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal.
Mercier BC; Cottalorda A; Coupet CA; Marvel J; Bonnefoy-Bérard N
J Immunol; 2009 Feb; 182(4):1860-7. PubMed ID: 19201838
[TBL] [Abstract][Full Text] [Related]
11. Antigen-induced coreceptor down-regulation on thymocytes is not a result of apoptosis.
McGargill MA; Hogquist KA
J Immunol; 1999 Feb; 162(3):1237-45. PubMed ID: 9973375
[TBL] [Abstract][Full Text] [Related]
12. Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4+ but not CD8+ T cells.
Prisco A; Vanes L; Ruf S; Trigueros C; Tybulewicz VL
Immunity; 2005 Sep; 23(3):263-74. PubMed ID: 16169499
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactions.
Mehal WZ; Sheikh SZ; Gorelik L; Flavell RA
Int Immunol; 2005 May; 17(5):531-8. PubMed ID: 15824070
[TBL] [Abstract][Full Text] [Related]
14. Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation.
Verdeil G; Chaix J; Schmitt-Verhulst AM; Auphan-Anezin N
Eur J Immunol; 2006 Dec; 36(12):3090-100. PubMed ID: 17111352
[TBL] [Abstract][Full Text] [Related]
15. Consequences of intrathymic TCR engagement by partial agonist on selection events and peripheral T cell activation program.
Auphan N; Simon AK; Asnagli H; Phillips RJ; Rincon M; Ghosh S; Flavell RA; Schmitt-Verhulst AM
J Immunol; 1998 May; 160(10):4810-21. PubMed ID: 9590228
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.
Liu SD; Lee S; La Cava A; Motran CC; Hahn BH; Miceli MC
Lupus; 2011 Apr; 20(5):473-84. PubMed ID: 21335401
[TBL] [Abstract][Full Text] [Related]
17. Defective T-cell receptor-induced apoptosis of T cells and rejection of transplanted immunogenic tumors in p53(-/-) mice.
Singh N; Huang L; Qin H
Eur J Immunol; 2010 Feb; 40(2):559-68. PubMed ID: 19950180
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells.
Apte SH; Baz A; Groves P; Kelso A; Kienzle N
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17475-80. PubMed ID: 18988742
[TBL] [Abstract][Full Text] [Related]
19. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
20. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
